AUNA advances oncology push in Mexico with new Oncocenter, insurer tie-ups, and rising revenues, signaling strong traction in a key growth market.
Auna S.A. AUNA is currently executing on several growth initiatives in Mexico, which remains a large and underpenetrated market. Scaling and enhancing its oncology capabilities is a key part of this strategy. In October 2025, the company inaugurated a new Oncocenter at Doctors Hospital, Monterrey, designed to provide oncology services in a single location and be integrated with its regional healthcare network.
Auna plans to double the medical staff at the facility this year, with a focus on physicians concentrating their clinical practice within its healthcare network. This is backed by an agreement with a leading insurer that includes targeted deductible structures and financial incentives to direct policyholders to its oncology services. Management expects these efforts to boost growth in high-complexity case volumes and support better utilization of the company’s specialized oncology capacity.
Auna had also signed an exclusive, five-year agreement with a physician group at Opción Oncología, under which it will gradually integrate all of their private oncology treatments within its network, improving care coordination and the patient experience. In the fourth quarter of 2025, oncology revenues increased 35% on a sequential basis, supported by both the ongoing integration of Opción Oncología and the rollout of Oncocenter.
The company also sees strong potential for OncoMexico, its complementary oncology insurance product launched in July 2024. Auna is expanding the OncoMexico network’s national footprint via partnerships with top medical Institutions, like Médica Sur and San Javier, to provide integrated care across the region’s most economically dynamic urban centers. It also plans to invest nearly $500 million in Mexico’s principal cities during the next three to five years, to build additional capacity and better serve local communities.
AUNA’s Peer Updates
Aveanna Healthcare Holdings AVAH announced its fourth-quarter 2025 results last month, with revenue up 27.4% year over year, led by strength in all three of its operating divisions. Adjusted EBITDA improved 54%, mainly due to the improved rate and volume environment and ongoing cost savings initiatives.
In addition, Aveanna entered into an agreement to acquire Family First Holding, LLC., a scaled, multi-state provider of pediatric home care, for $175.5 million. The transaction, subject to customary adjustments, is set to expand the company’s specialized care model across an enhanced geographic footprint.
AdaptHealth Corp.’s AHCO fourth-quarter 2025 net revenue fell 1.2% year over year, but increased 1.7% on an organic basis. The company set patient census records in Sleep Health, Respiratory Health, and Wellness at Home, and a retention record in Diabetes Health. Further, the debt balance was reduced by another $25 million, bringing the year-to-date total to $250 million. Throughout the year, AdaptHealth implemented a new operating model that drove standardization and process maturity across the enterprise.
Year to date, Auna shares have risen 11.8% against the industry’s 12.2%% decline. The S&P 500 Composite gained 2.8% during the same time frame.
Image Source: Zacks Investment Research
Auna is trading at a forward, five-year, price-to-sales (P/S) of 0.30X, lower than its median and industry average.
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for Auna’s 2026 and 2027 earnings has remained constant at 87 cents and 98 cents, respectively, for the past 30 days.
Image Source: Zacks Investment Research
AUNA carries a Zacks Rank #3 (Hold) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
This company targets millennial and Gen Z audiences, generating nearly $1 billion in revenue last quarter alone. A recent pullback makes now an ideal time to jump aboard. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X $TWTR Imaging which shot up +129.6% in little more than 9 months.
Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
AdaptHealth Corp. (AHCO): Free Stock Analysis Report
Aveanna Healthcare Holdings Inc. (AVAH): Free Stock Analysis Report
Auna S.A. (AUNA): Free Stock Analysis Report
Join 500,000+ readers who start their day with Quartz.
By subscribing, you agree to our Terms of Service and Privacy Policy.
